Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Tvardi Therapeutics, Incorporated · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
hepatocellular-carcinomapembrolizumab
hepatocellular carcinoma, tti-101, pembrolizumab, atezolizumab, bevacizumab, revert, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 870006
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.